Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Mutagenic DNA Lesions in Normal Hematopoietic Stem Cells Persist for Years Causing Distinct Patterns of Mutation

Blood (2024) 144 (Supplement 1): 2673.

https://doi.org/10.1182/blood-2024-208773

Published: 2024

Journal Articles

Trial in Progress: A Multicenter, Open Label, Randomized, Phase 2 Study of Venetoclax and Azacitidine Plus Cusatuzumab Versus Venetoclax and Azacitidine Alone in Newly Diagnosed AML Patients Who Are Not Candidates for Intensive Therapy

Gail J. Roboz, Ahmed Aribi, Adrian Ochsenbein, Carsten Riether, Monic J. Stuart, Emily Mitchell, Komal Changela, Adam George, Michael Boyiadzis, Clayton Smith, Thomas Pabst

Blood (2024) 144 (Supplement 1): 1504.2.

https://doi.org/10.1182/blood-2024-202648

Published: 2024

Journal Articles

Pervasive Positive Selection in Blood in 200,618 Individuals and Novel Drivers of Clonal Hematopoiesis

Nicholas Bernstein, Michael Spencer Chapman, Kudzai Nyamondo, Zhenghao Chen, Nicholas Williams, Emily Mitchell, Peter Campbell, Robert L Cohen, Jyoti Nangalia

Blood (2023) 142 (Supplement 1): 4062.

https://doi.org/10.1182/blood-2023-185188

Published: 2023

Journal Articles

Clonal Dynamics after Haematopoietic Stem Cell Transplantation Using Genome-Wide Somatic Mutations

Michael Spencer Chapman, C. Matthias Wilk, Steffen Boettcher, Emily Mitchell, Kevin J Dawson, Larisa V. Kovtonyuk, Jan Müller, Nicholas Williams, Jyoti Nangalia, Markus G Manz, Peter J. Campbell

Blood (2022) 140 (Supplement 1): 1572–1573.

https://doi.org/10.1182/blood-2022-166701

Published: 2022

Journal Articles

Replacing Procarbazine with Dacarbazine in Escalated Beacopp Dramatically Reduces the Post Treatment Haematopoietic Stem and Progenitor Cell Mutational Burden in Hodgkin Lymphoma Patients with No Apparent Loss of Clinical Efficacy

Blood (2022) 140 (Supplement 1): 1761–1764.

https://doi.org/10.1182/blood-2022-166543

Published: 2022

Journal Articles

Clonal Hematopoiesis in Mice Is Common with Age and Accelerated By Microbial Exposure

Chiraag D. Kapadia, Matthew Yousefzadeh, Emily Mitchell, Duy Le, Nicholas Williams, Marcus A. Florez, Katherine Y. King, Laura Niedernhofer, Jyoti Nangalia, Margaret A. Goodell

Blood (2022) 140 (Supplement 1): 5741–5742.

https://doi.org/10.1182/blood-2022-168231

Published: 2022

Journal Articles

Venetoclax-Based Non-Intensive Combinations Successfully Salvage Molecular Relapse of Acute Myeloid Leukemia and Are an Important Bridge to Cellular Therapy in Relapsed/Refractory Disease - Real-World Data from a UK-Wide Programme

Blood (2022) 140 (Supplement 1): 9016–9018.

https://doi.org/10.1182/blood-2022-167097

Published: 2022

Journal Articles

Unique molecular and functional features of extramedullary hematopoietic stem and progenitor cell reservoirs in humans

Blood (2022) 139 (23): 3387–3401.

https://doi.org/10.1182/blood.2021013450

Published: 2022

Includes: Supplemental data

Journal Articles

The Longitudinal Dynamics and Natural History of Clonal Hematopoiesis

Blood (2021) 138 (Supplement 2): LBA-2.

https://doi.org/10.1182/blood-2021-154938

Published: 2021

Journal Articles

Clonal Tracking By Whole Genome Sequencing Permits Comprehensive Mapping of the Genomic Landscape in Pre- and Post-Gene Therapy Sickle Cell Patients

Alyssa H. Cull, Michael Spencer Chapman, Marioara Ciuculescu, Emily Mitchell, Myriam Armant, Grace Boyd, Erica B. Esrick, David A. Williams, Peter J. Campbell, David G. Kent

Blood (2021) 138 (Supplement 1): 559.

https://doi.org/10.1182/blood-2021-152262

Published: 2021

Journal Articles

Clonal Dynamics of Normal Haematopoiesis with Human Ageing

Blood (2021) 138 (Supplement 1): 598.

https://doi.org/10.1182/blood-2021-150152

Published: 2021

Journal Articles

Long-Term Clonal Dynamics upon Allogeneic Haematopoietic Stem Cell Transplantation Revealed Using Somatic Mutations As Clonal Tracking Marks in HSC Donor and Recipient Pairs

Michael Spencer Chapman, C. Matthias Wilk, Steffen Boettcher, Larisa V. Kovtonyuk, Emily Mitchell, Nicholas Williams, Jyoti Nangalia, Markus G Manz, Peter J. Campbell

Blood (2021) 138 (Supplement 1): 3813.

https://doi.org/10.1182/blood-2021-146151

Published: 2021

Journal Articles

Clonal hematopoiesis and therapy-related myeloid neoplasms following neuroblastoma treatment

Tim H. H. Coorens, Grace Collord, Wanhua Lu, Emily Mitchell, Jannat Ijaz, Thomas Roberts, Thomas R. W. Oliver, G. A. Amos Burke, Michael Gattens, Emmy Dickens, Jyoti Nangalia, Marc Tischkowitz, John Anderson, Adam Shlien, Anna L. Godfrey, Matthew J. Murray, Sam Behjati

Blood (2021) 137 (21): 2992–2997.

https://doi.org/10.1182/blood.2020010150

Published: 2021

Includes: Supplemental data

Journal Articles

Life History of Normal Human Lymphocytes Revealed By Somatic Mutations

Heather E Machado, PhD, Nina Friesgaard Øbro, Emily Mitchell, Megan Davies, Anthony R Green, Kourosh Saeb-Parsy, Daniel James Hodson, MD PhD, David Kent, PhD, Peter J Campbell

Blood (2019) 134 (Supplement_1): 1045.

https://doi.org/10.1182/blood-2019-128188

Published: 2019

Journal Articles

Clonal approaches to understanding the impact of mutations on hematologic disease development

Jyoti Nangalia, Emily Mitchell, Anthony R. Green

Blood (2019) 133 (13): 1436–1445.

https://doi.org/10.1182/blood-2018-11-835405

Published: 2019

NARROW

Mutagenic DNA Lesions in Normal Hematopoietic Stem Cells Persist for Years Causing Distinct Patterns of Mutation

Trial in Progress: A Multicenter, Open Label, Randomized, Phase 2 Study of Venetoclax and Azacitidine Plus Cusatuzumab Versus Venetoclax and Azacitidine Alone in Newly Diagnosed AML Patients Who Are Not Candidates for Intensive Therapy

Pervasive Positive Selection in Blood in 200,618 Individuals and Novel Drivers of Clonal Hematopoiesis

Clonal Dynamics after Haematopoietic Stem Cell Transplantation Using Genome-Wide Somatic Mutations

Replacing Procarbazine with Dacarbazine in Escalated Beacopp Dramatically Reduces the Post Treatment Haematopoietic Stem and Progenitor Cell Mutational Burden in Hodgkin Lymphoma Patients with No Apparent Loss of Clinical Efficacy

Clonal Hematopoiesis in Mice Is Common with Age and Accelerated By Microbial Exposure

Venetoclax-Based Non-Intensive Combinations Successfully Salvage Molecular Relapse of Acute Myeloid Leukemia and Are an Important Bridge to Cellular Therapy in Relapsed/Refractory Disease - Real-World Data from a UK-Wide Programme

Unique molecular and functional features of extramedullary hematopoietic stem and progenitor cell reservoirs in humans

The Longitudinal Dynamics and Natural History of Clonal Hematopoiesis

Clonal Tracking By Whole Genome Sequencing Permits Comprehensive Mapping of the Genomic Landscape in Pre- and Post-Gene Therapy Sickle Cell Patients

Clonal Dynamics of Normal Haematopoiesis with Human Ageing

Long-Term Clonal Dynamics upon Allogeneic Haematopoietic Stem Cell Transplantation Revealed Using Somatic Mutations As Clonal Tracking Marks in HSC Donor and Recipient Pairs

Clonal hematopoiesis and therapy-related myeloid neoplasms following neuroblastoma treatment

Life History of Normal Human Lymphocytes Revealed By Somatic Mutations

Clonal approaches to understanding the impact of mutations on hematologic disease development

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only